One trend continues to reshape the in vitro diagnostics (IVD) industry year after year: acquisitions. Since the 1990s, the biggest IVD companies have frequently used acquisitions to boost their revenue and keep shareholders happy. But acquisitions have another consequence. The clinical laboratories and anatomic pathology groups buying instruments, automation, and test kits from one IVD […]
To access this post, you must purchase The Dark Report.